DuPont 2015 Annual Report Download - page 117

Download and view the complete annual report

Please find page 117 of the 2015 DuPont annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)
(Dollars in millions, except per share)
F-58
22. SEGMENT INFORMATION
The company consists of 10 businesses which are aggregated into 6 reportable segments based on similar economic characteristics,
the nature of the products and production processes, end-use markets, channels of distribution and regulatory environment. The
company's reportable segments are Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health,
Performance Materials and Safety & Protection. The company includes certain businesses not included in the reportable segments,
such as pre-commercial programs, nonaligned businesses and pharmaceuticals in Other. Pre-commercial programs include
approximately $400 for the investment in a cellulosic biofuel facility in Nevada, Iowa which includes all material, engineering,
and technical design costs involved in construction of the facility. The facility is expected to commence production in the second
half of 2016.
Major products by segment include: Agriculture (corn hybrids and soybean varieties, herbicides, fungicides and insecticides);
Electronics & Communications (photopolymers and electronic materials); Industrial Biosciences (enzymes and bio-based
materials); Nutrition & Health (cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients); Performance
Materials (engineering polymers, packaging and industrial polymers, films and elastomers); and Safety & Protection (nonwovens,
aramids and solid surfaces). The company operates globally in substantially all of its product lines.
In general, the accounting policies of the segments are the same as those described in Note 1. Exceptions are noted as follows and
are shown in the reconciliations below. Segment net assets includes net working capital, net property, plant and equipment, and
other noncurrent operating assets and liabilities of the segment. Depreciation and amortization includes depreciation on research
and development facilities and amortization of other intangible assets, excluding write-down of assets. Effective July 1, 2015,
certain corporate expenses will now be included in segment operating earnings. Reclassifications of prior year data have been
made to conform to current year classifications.
Segment operating earnings is defined as income (loss) from continuing operations before income taxes excluding significant pre-
tax benefits (charges), non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate
expenses and interest. Non-operating pension and other postretirement employee benefit costs includes all of the components of
net periodic benefit cost from continuing operations with the exception of the service cost component.